Emerging Markets Earnings Roundup: Abbott Laboratories (Part 2)
This article was originally published in PharmAsia News
Executive Summary
Abbott Laboratories now sees 40% of sales from emerging markets and has said a corner has been turned on its dairy nutrition business in China.